Home Clinical Topics New FDA regulation for improving safety reporting in clinical trials discussed in...

New FDA regulation for improving safety reporting in clinical trials discussed in The New England Journal of Medicine.

The June 8 edition of The New England Journal of Medicine includes “New FDA Regulation to Improve Safety Reporting in Clinical Trials.” Read here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here